No Prescription |
 |
 | ||
|
Selsun Blue Deep Cleansing Generic Selenium Sulphide |
|
| ||
No Prescription » Prescription Drugs 14 » Selsun Blue Deep Cleansing Generic Selenium Sulphide Selsun Blue is specifically designed to fight dandruff and its associated itching and flaking from the first wash. Selsun Blue Replenishing Anti-dandruff Shampoo contains a vitamin enriched deep conditioning system with Vitamin E and the B Vitamin panthenol to moisturise hair and scalp. Selsun Blue Anti-dandruff Shampoo also leaves hair looking healthy and feeling clean soft and manageable. Selsun Blue Anti-Dandruff Shampoo:Clears dandruffFights itchReplenishes for all hair typesIs vitamin enriched to moisturise hair and scalp.Selsun Blue is gentle enough for everyday use and should be used regularly for best results. Directions for use: Wet hair thoroughly. Shake bottle well. Lather rinse thoroughly and repeat. Ingredients 1% Selenium Sulphide Warning For external use only. Avoid contact with eyes and damaged skin. Rinse thoroughly from the hair before colouring bleaching or perming. Selsun Blue should not be used for two days before of after any of these treatments. Avoid contact with jewellry. Store below 30 degrees C. Buy Selsun Blue Deep Cleansing Generic Selenium Sulphide and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About Selsun Blue Deep Cleansing Generic Selenium Sulphide: Product Type: Prescription Drugs 14 Selsun Blue Deep Cleansing ( Generic Selenium Sulphide ) Selsun Blue Deep Cleansing (Generic Selenium Sulphide) Generic Selenium Sulphide 1% Generic Selenium Sulphide Selsun Blue Deep Cleansing
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
